<DOC>
	<DOCNO>NCT02797756</DOCNO>
	<brief_summary>Using active cohort child Airway gastrointestinal endoscopy perform , investigator conduct chart review obtain relevant clinical data investigator use aliquot airway sample obtain clinically indicated bronchoscopy microbiome analysis . A case-control study design use study whether subject CC GER distinct lung microbiome increase inflammation compare subject CC without GER determine whether microbiome degree inflammation relate type GER ( acidic versus nonacidic ) .</brief_summary>
	<brief_title>Impact Gastroesophageal Reflux Aspiration Airway Inflammation Microbiome Children With Chronic Cough</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Cough</mesh_term>
	<criteria>Children ( Age 0 24 year ) refer NYU Pediatric AeroDigestive Center evaluate CC ( &gt; 4weeks ) . Antibiotic steroid ( inhaled systemic ) use within prior oneweek . Rationale : Antibacterial drug immunemodulators confounders may impact microbiome inflammation . While long period free Antibacterial drug immunemodulators would desire , would unethical usual standard care withdraw treatment long period time . Interstitial Lung Disease pneumonia Xray Cystic fibrosis Primary ciliary dyskinesia Immunodeficiency syndromes Major airway abnormality Proton pump inhibitor/H2receptor antagonist therapy within prior 2 week</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>